Compile Data Set for Download or QSAR
Report error Found 67 Enz. Inhib. hit(s) with all data for entry = 11873
TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656079(US20240067645, Example 41)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656065(US20240067645, Example 27)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656066(US20240067645, Example 28)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656067(US20240067645, Example 29)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656068(US20240067645, Example 30)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656070(US20240067645, Example 32)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656039(US20240067645, Example 1)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656073(US20240067645, Example 35)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656074(US20240067645, Example 36)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656075(US20240067645, Example 37)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656077(US20240067645, Example 39)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656072(US20240067645, Example 34)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656080(US20240067645, Example 42)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656081(US20240067645, Example 43)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656086(US20240067645, Example 48)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656088(US20240067645, Example 50)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656089(US20240067645, Example 51)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656092(US20240067645, Example 54)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656098(US20240067645, Example 60)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656099(US20240067645, Example 61)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656104(US20240067645, Example 66)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656105(US20240067645, Example 67)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656040(US20240067645, Example 2)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656060(US20240067645, Example 22)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656043(US20240067645, Example 5)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656051(US20240067645, Example 13)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656056(US20240067645, Example 18)
Affinity DataIC50: 300nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656082(US20240067645, Example 44)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656083(US20240067645, Example 45)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656061(US20240067645, Example 23)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656084(US20240067645, Example 46)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656085(US20240067645, Example 47)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656047(US20240067645, Example 9)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656087(US20240067645, Example 49)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656046(US20240067645, Example 8)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656091(US20240067645, Example 53)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656044(US20240067645, Example 6)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656093(US20240067645, Example 55)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656095(US20240067645, Example 57)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656097(US20240067645, Example 59)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656100(US20240067645, Example 62)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656103(US20240067645, Example 65)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656041(US20240067645, Example 3)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656049(US20240067645, Example 11)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656058(US20240067645, Example 20)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656057(US20240067645, Example 19)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656069(US20240067645, Example 31)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656059(US20240067645, Example 21)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656071(US20240067645, Example 33)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetDiacylglycerol kinase alpha(Human)
Lg Chem

US Patent
LigandPNGBDBM656055(US20240067645, Example 17)
Affinity DataIC50: 2.65E+3nMAssay Description:First, 3×OAG (3 mM)/ATP (0.45 mM) substrate solution was prepared from 1× substrate assay buffer (40 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM DTT, 0.4 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: